Miller D D, Flaum M, Arndt S, Fleming F, Andreasen N C
Mental Health Clinical Research Center, University of Iowa Hospitals and Clinics, Iowa City 52242-1057.
Neuropsychopharmacology. 1994 Aug;11(1):11-20. doi: 10.1038/npp.1994.31.
Although it is generally accepted that antipsychotic treatment improves the negative symptoms of schizophrenia in the context of improvement of positive symptoms, exactly how and to what extent they effect "primary" negative symptoms remains controversial. Antipsychotic treatment may reduce only those negative symptoms secondary to positive or depressive symptoms, and may have minimal, if any effect, on negative symptoms that represent a primary psychopathological trait manifestation of schizophrenia. In an effort to further examine this issue, we prospectively assessed negative, positive, depressive, and extrapyramidal symptoms following the discontinuation of antipsychotic medication. Fifty-nine DSM III-R schizophrenic patients underwent a three-week drug wash as part of our neuroimaging protocols. We assessed psychopathological status and adverse effects utilizing various rating instruments (i.e., Scale for Assessment of Positive Symptoms [SAPS], Scale for Assessment of Negative Symptoms [SANS], Hamilton Rating Scale for Depression, and Simpson-Angus Extrapyramidal) at baseline and weekly during this three-week period. Negative symptoms, as measured by the SANS, worsened significantly during the three-week drug wash. Positive symptoms showed a less consistent change with symptoms of disorganization worsening and with psychotic symptoms remaining the same. The changes in negative symptoms during the drug-free period were correlated with the changes in psychosis and disorganization, but not with changes in depression or extrapyramidal side effects. We were not able to substantiate if the worsening in negative symptoms was a direct result of the worsening of positive symptoms or if they were changing simultaneously, but independent of each other.
虽然人们普遍认为抗精神病药物治疗在改善精神分裂症阳性症状的同时也能改善阴性症状,但它们究竟如何以及在多大程度上影响“原发性”阴性症状仍存在争议。抗精神病药物治疗可能仅能减轻那些继发于阳性或抑郁症状的阴性症状,而对代表精神分裂症原发性精神病理特征表现的阴性症状可能影响甚微,甚至没有影响。为了进一步研究这个问题,我们前瞻性地评估了停用抗精神病药物后的阴性、阳性、抑郁和锥体外系症状。59名符合DSM III-R标准的精神分裂症患者作为我们神经影像学研究方案的一部分,进行了为期三周的药物洗脱期。在这三周内,我们在基线时以及每周使用各种评定工具(即阳性症状评定量表[SAPS]、阴性症状评定量表[SANS]、汉密尔顿抑郁评定量表和辛普森-安格斯锥体外系评定量表)评估精神病理状态和不良反应。用SANS评定的阴性症状在三周的药物洗脱期内显著恶化。阳性症状变化不太一致,其中紊乱症状恶化,而精神病性症状保持不变。停药期阴性症状的变化与精神病症状和紊乱症状的变化相关,但与抑郁症状或锥体外系副作用的变化无关。我们无法证实阴性症状的恶化是阳性症状恶化的直接结果,还是它们同时发生变化但彼此独立。